Enalapril Maleate Tablets, USP 20 mg
Rising Pharma is recalling Enalapril Maleate 20 mg tablets (NDC 64980-688-10) due to failed impurities test.
Do not use this medication. Contact your pharmacy or healthcare provider immediately to obtain a replacement or alternative medication. Return the affected bottle to your pharmacy for proper disposal.
Recall at a glance
- Quantity recalled
- 675 bottles
Why it was recalled
Rising Pharma Holdings, Inc. is recalling Enalapril Maleate Tablets, USP, 20 mg in 1,000-count bottles (NDC 64980-688-10) manufactured by Unique Pharmaceutical Laboratories due to failed impurities specifications. The affected lot failed the Organic Impurities Test and may contain out-of-specification levels of impurities or degradation products.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Enalapril Maleate Tablets, USP
- Lot code
- GEH25023, 2027
- Strength
- 20 mg
- NDC / UPC
- NDC 64980-688-10
Where it was sold
Distributed nationwide.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
Other recent recalls from JB Chemicals and Pharmaceuticals Ltd
Editorial summary by Recall Canary · summary updated 2026-05-06 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification